Cargando…
Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786822/ https://www.ncbi.nlm.nih.gov/pubmed/29404273 http://dx.doi.org/10.3389/fonc.2017.00330 |
| _version_ | 1783295830508175360 |
|---|---|
| author | Cintas, Célia Guillermet-Guibert, Julie |
| author_facet | Cintas, Célia Guillermet-Guibert, Julie |
| author_sort | Cintas, Célia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5786822 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57868222018-02-05 Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? Cintas, Célia Guillermet-Guibert, Julie Front Oncol Oncology Frontiers Media S.A. 2018-01-22 /pmc/articles/PMC5786822/ /pubmed/29404273 http://dx.doi.org/10.3389/fonc.2017.00330 Text en Copyright © 2018 Cintas and Guillermet-Guibert. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Cintas, Célia Guillermet-Guibert, Julie Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? |
| title | Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? |
| title_full | Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? |
| title_fullStr | Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? |
| title_full_unstemmed | Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? |
| title_short | Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important? |
| title_sort | heterogeneity of phosphatidylinositol-3-kinase (pi3k)/akt/mammalian target of rapamycin activation in cancer: is pi3k isoform specificity important? |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786822/ https://www.ncbi.nlm.nih.gov/pubmed/29404273 http://dx.doi.org/10.3389/fonc.2017.00330 |
| work_keys_str_mv | AT cintascelia heterogeneityofphosphatidylinositol3kinasepi3kaktmammaliantargetofrapamycinactivationincancerispi3kisoformspecificityimportant AT guillermetguibertjulie heterogeneityofphosphatidylinositol3kinasepi3kaktmammaliantargetofrapamycinactivationincancerispi3kisoformspecificityimportant |